ArticleJournal of cardiothoracic surgery2026
Advanced cystic lung cancer complicated with pulmonary lymphangitic carcinomatosis: a case report.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary lymphangitic carcinomatosis (PLC) is a life-threatening complication of intrathoracic malignant tumors and is characterized by tumor cell spread via the pulmonary lymphatic system. The lymphatic vessel dilation, interstitial thickening and edema caused by the tumor can lead to progressive breathing difficulties, which is a typical clinical feature of this condition. Pleuritic pain may occur if subpleural lymphatics are obstructed, but clinical manifestations are often non-specific. Most patients are diagnosed at an advanced stage with respiratory failure, and there is no definitive therapy; thus, the overall prognosis remains poor with short survival. Herein, we report a case of advanced cavitary lung adenocarcinoma complicated with PLC, with pericardial effusion and mediastinal or pericardial metastases. The patient underwent palliative surgery followed by sequential chemotherapy and immunotherapy and had survived for 41 months as of the last follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.